Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.
Pediatr Crit Care Med. 2013 Jun;14(5):462-6. doi: 10.1097/PCC.0b013e31828a7287.
Limited evidence exists on the use of corticosteroids in pediatric shock. We sought to determine physicians' practices and beliefs with regard to the management of pediatric shock.
Cross-sectional, Internet-based survey.
Canada.
Physicians identified as practicing pediatric intensive care in any of 15 academic centers.
Seventy of 97 physicians (72.2%) responded. Physicians stated that they were more likely to prescribe steroids for septic shock than for shock following cardiac surgery (odds ratio, 1.9 [95% CI, 0.9-4.3]) or trauma (odds ratio, 11.46 [95% CI, 2.5-51.2]), and 91.4% (64/70) would administer steroids to patients who had received 60 cc/kg of fluid and two or more vasoactive medications. Thirty-five percent of respondents (25/70) reported that they rarely or never conducted adrenal axis testing before giving steroids to patients in shock. Eighty-seven percent of respondents (61/70) stated that the role of steroids in the treatment of fluid and/or vasoactive drug-dependent shock needed to be clarified and that 84.3% would be willing to randomize patients into a trial of steroid efficacy who were fluid resuscitated and on one high-dose vasoactive medication. However, 74.3% stated that they would start open-label steroids in patients who required two high-dose vasoactive medications.
This survey provides information on the stated beliefs and practices of pediatric critical care physicians with regard to the use of steroids in fluid and/or vasoactive drug-dependent shock. Clinicians feel that the role of steroids in shock still requires clarification and that they would be willing to randomize patients into a trial. This survey may be useful as an initial framework for the development of a future trial on the use of steroids in pediatric shock.
有关皮质类固醇在儿科休克中的应用,目前仅有少量证据。本研究旨在明确儿科重症监护医师在儿科休克管理方面的实践和信念。
横断面、基于互联网的调查。
加拿大。
15 个学术中心中被认为从事儿科重症监护的医师。
70 名(72.2%)参与调查的医师报告了他们的实践情况。医师表示,他们更倾向于为感染性休克患者开具类固醇,而不是为心脏手术后(比值比 1.9[95%CI,0.9-4.3])或创伤后(比值比 11.46[95%CI,2.5-51.2])休克患者开具类固醇。91.4%(64/70)的医师会为已接受 60cc/kg 液体和两种或以上血管活性药物治疗的患者使用类固醇。35%(25/70)的受访者报告称,他们在给休克患者使用类固醇之前很少或从不进行肾上腺轴检测。87%(61/70)的受访者表示,类固醇在治疗液体和(或)血管活性药物依赖型休克中的作用需要进一步明确,84.3%的受访者愿意将接受液体复苏和一种高剂量血管活性药物治疗的患者随机分组,以评估类固醇的疗效。然而,74.3%的受访者表示,他们会在患者需要两种高剂量血管活性药物治疗时开始使用开放性类固醇。
本调查提供了儿科重症监护医师在液体和(或)血管活性药物依赖型休克中使用类固醇的信念和实践方面的信息。临床医生认为类固醇在休克中的作用仍需进一步阐明,他们愿意将患者随机分组进行试验。本调查可为未来儿科休克中类固醇应用的研究提供初步框架。